Patent · US Expired

Pharmaceutical formulations

US4556671A · kind A · utility

19Cited by
1References
1Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 22, 1981
Grant dateDec 3, 1985
Priority date
Expiry dateMay 22, 2001

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07C243/00
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Heterocyclic compounds of formula (I) ##STR1## and their acid addition salts, when administered topically, exhibit anti-inflammatory activity and do not produce the side-effects associated with the administration of certain other anti-inflammatories. The compounds of formula (I) may be administered topically as the compound alone or in a suitable topical pharmaceutical formulation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.